← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

16,645

Price

$0

Filed

Jun 16

Insider

Name

Betz Stephen F.

Title

Chief Scientific Officer

CIK

0001886575

Roles

Officer

Transaction Details

Transaction Date

2025-06-12

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

58,198

Footnotes

Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan. | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $32.23 per share. The range of sales prices on the transaction date was $31.67 to $32.65 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | The option vested in 48 equal monthly installments beginning on April 16, 2018. | The option vested in 48 equal monthly installments beginning on June 25, 2018.

Filing Info

Accession No.

0000950170-25-086804

Form Type

4

Issuer CIK

0001658247

Betz Stephen F.'s History

Date Ticker Type Value
2025-12-26 CRNX M $34K
2025-12-26 CRNX M $0
2025-06-12 CRNX M $137K
2025-06-12 CRNX M $154K
2025-06-12 CRNX $3.1M
2025-06-12 CRNX M $0
2025-06-12 CRNX M $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08